Oleg Nodelman is Director & 10% Owner at Zymeworks Inc. (ZYME). They have made 11 open-market trades across 6 companies since 2013, most recently 2026-01-12.
CIK 0001454385
11 open-market purchases totalling $94.0M since 2013, never a sale. Across 11 scored buys the stock is down 0.6% at ninety days, and 4.7 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 27% | 45% | 45% |
| Avg Move | -7.9% | -4.5% | -0.6% |
| Alpha | -5.4% | -4.8% | -4.7% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKTS | BUY | 2026-01-12 | 2026-01-12 | $18.00 | $40.0M | -6.1% | -21.6% | -24.6% |
| ZYME | BUY | 2025-04-03 | 2025-04-07 | $11.43 | $7.2M | +4.2% | +2.5% | +18.3% |
| ZYME | BUY | 2025-03-11 | 2025-03-13 | $12.12 | $26.2M | -1.2% | -15.1% | -0.6% |
| NUVB | BUY | 2023-02-19 | 2023-09-21 | $1.26 | $6.7M | -11.9% | -19.6% | -1.4% |
| ANAB | BUY | 2021-04-30 | 2021-05-04 | $23.24 | $5.1M | +5.4% | -3.8% | -5.0% |
| ANAB | BUY | 2021-04-23 | 2021-04-27 | $23.63 | $3.5M | +6.1% | -1.4% | -2.3% |
| KIN | BUY | 2014-09-29 | 2014-09-30 | $9.56 | $956K | -3.8% | +2.6% | +2.6% |
| KIN | BUY | 2014-08-27 | 2014-08-29 | $10.85 | $510K | -3.8% | +2.6% | +2.6% |
| KIN | BUY | 2014-08-25 | 2014-08-27 | $10.50 | $895K | -3.8% | +2.6% | +2.6% |
| GNVC | BUY | 2014-05-22 | 2014-05-27 | $2.24 | $54K | -68.2% | -1.1% | -1.1% |
| KIN | BUY | 2013-12-12 | 2013-12-13 | $7.00 | $2.8M | -3.8% | +2.6% | +2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.